Satellite Symposia

Canadian Hidradenitis Suppurativa Foundation

The Canadian Hidradenitis Suppurativa Foundation (CHSF)* is pleased to host a Hidradenitis Suppurativa (HS) Symposium prior to the 23^rd World Congress of Dermatology. The purpose of this symposium is to update recent advances in HS & showcase world HS expert dermatologists. The program has been organized with the collaboration of the Presidents of the American Hidradenitis Suppurativa Foundation Inc. (HSF) and the European Hidradenitis Suppurativa Foundation (EHSF).

* The CHSF is supported in part by a grant from AbbVie

Click here for your invitation to this satellite symposium!

Agenda

13:00-13:05         Welcome Afsaneh Alavi (Canada)

13:05-13:10         Introduction Paul Hazen (USA)

13:10-13:20         Epidemiology and the burden of the disease Gregor Jemec (Denmark)

13:20-13:30         An update on pathophysiology Errol Prens (Netherlands)

13:30-13:40         New insights into diagnosis of HS & Classifications Alexa Boer Kimball (USA)

13:40-13:50         Acne / HS / Auto-inflammatory syndrome Dae Hun Suh (Korea)

13:50-14:00         The role of Environmental factors on HS Qiang Ju (China)

14:00-14:15         Discussion Group

14:15-14:20         Introduction Christos Zouboulis (Germany)

14:20-14:30         Comorbidity in hidradenitis suppurativa Iben Miller (Denmark)

14:30-14:40         Identifying research gaps in hidradenitis suppurativa  John Ingram (UK)

14:40-14:50         Factors associated with hidradenitis suppurativa severity  Hessel van der Zee (Netherlands)

14:50-15:00         Cancer and HS Ichiro Kurokawa (Japan)

15:00-15:15         Discussion Group

15:15-15:25         Break Break

15:25-15:30         Introduction Gregor Jemec (Denmark)

15:30-15:40         Current treatment algorithm Christos Zouboulis (Germany)

15:40-15:50         Role of diet in HS F W (Bill) Danby (USA)

15:50-16:00         Wound healing and topical therapy Robert Kirsner (USA)

16:00-16:10         Traditional systemic treatment Raed Alhusyen (Canada)

16:10-16:20         Discussion Group

16:20-16:25         Introduction  Gary Sibbald (Canada)

16:25-16:35         The role of laser therapy  Iltefat Hamzavi (USA)

16:35-16:45         Pitfalls in Hidradenitis suppurativa surgery Falk Bechara (Germany)

16:45-16:55         The role of biologics Alain Brassard (Canada)

16:55-17:05         Implementation of European Guidelines Wayne Gulliver (Canada)

17:05-17:20         Discussion and Conclusion Group and Alain Brassard (Canada)

Acne scarring: From physiopathology to prevention, sponsored by Galderma

Acne vulgaris is associated with the development of challenging-to-treat atrophic scars. It is not well known why some acne subjects are more prone to scar than others. This symposium highlights the most recent data on the following: (1) demonstration of a different innate immunity profile in scar-prone compared with non-scar-prone acne subjects in both normal and inflammatory skin; (2) a 6-month study documenting filiation between primary and secondary acne lesions; and (3) exploratory studies evaluating the effect of adapalene 0.3% gel and adapalene 0.1%/benzoyl peroxide 2.5% fixed-dose combination gel in preventing the occurrence of and/or improving pre-existing atrophic acne scars.

Click here for your invitation to this satellite symposium!

Advances in Energy-based Nonsurgical Tissue Lifting, sponsored by Merz

Historically limited to surgical interventions, more recent aesthetic approaches for facilitating a younger appearance include energy-based interventions that afford short-duration enhancements to specific targets, including the face, neck, and other areas of tissue laxity. Lasers and radiofrequency technologies facilitate collagen remodeling, ultimately effecting tissue tightening, and can also address problems with skin irregularities or scarring to afford longer-duration benefits. New devices using micro-focused ultrasonic (MFUS) energy are able to penetrate the deep skin and foundational layers, providing both lifting and tightening, with benefits persisting for long durations – of more than a few years. Each energy-based approach has a unique set of indications, benefits, and drawbacks. This program, which includes a live demonstration, will educate participants about energy-based tissue lifting techniques, where they “fit” within the rejuvenation continuum, and how to select appropriate patients.

A Series of Debates to take Psoriasis Management Forward, sponsored by Novartis Pharma AG

This symposium will address a number of key questions relating to the psoriasis management through a series of mini debates. The debates will focus on (i) treatment goals in psoriasis therapy (should we now be aiming for at least PASI 90?); (ii) the place of novel biologics in the treatment of psoriasis patients with psoriatic arthritis; and (iii) considerations in optimizing first-line systemic treatment for moderate to severe psoriasis. With a brief rebuttal, expert panel discussion and audience vote planned following each debate, this promises to be a lively, interactive session.

Click here for your invitation to this satellite symposium!

Agenda

17:00-17:05         Welcome and Introduction (including overview of symposium format)

17:05-17:35         Debate 1: Is PASI 90 the new PASI 75?

17:35-18:05         Debate 2: Anti-TNFs as the gold standard for treating PsA: for how much longer?

18:05-18:35         Debate 3: Is it time for biologics as first-line treatment in psoriasis?

18:35-18:55         Question & Answer Session

18:55-19:00         Close

The Impact of Oxidative Stress on Hair Condition: Treatment of Pre- and Post-Emergent Factors for Lifetime Hair Health, sponsored by Procter and Gamble – Head & Shoulders and Pantene

A healthy, dandruff free scalp and hair that is in good condition (healthy looking, strong and shiny) are highly desirable attributes for patients making both impact factors and solutions highly relevant to Dermatologists. Whilst the role of oxidative stress has been widely discussed in relation to skin appearance (health and premature ageing) relatively little focus has been placed on its role in impacting scalp health and hair condition. We will explore both the science behind the role of oxidative stress and its impact upon lifetime scalp and hair health in addition to offering practical solution for integration into patients’ at-home routines.

Click here for symposium details!

Patient Care in Psoriasis: Is it Time for a Paradigm Shift?, sponsored by Lilly

Psoriasis is a physically and/or socially debilitating chronic and systemic disease. However, emerging biologic treatments that target specific cytokines have raised expectations for the clinical management of psoriasis. Experience with newer biologic therapies suggests that more patients with psoriasis can achieve higher levels of clearance and more meaningful improvements in health-related quality of life outcomes, compared with existing treatments. In this symposium, psoriasis therapy area experts will discuss whether it is time for a paradigm shift in the clinical care of patients with psoriasis as these new treatment options may provide new perspectives for patients and physicians alike.

Click here for symposium details!

Advances in actinic keratosis: more than meets the eye, sponsored by LEO Pharma

Accurate diagnosis and treatment of actinic keratosis (AK) is essential as the lesions (both clinical and subclinical) are markers for and can progress through field cancerisation to invasive squamous cell carcinoma. Consequently, an ideal treatment for AK must clear clinically identifiable lesions and the area of field change. Lesion-directed treatments alone do not address field cancerisation, leaving patients at risk of developing new lesions and possibly SCC. In this symposium, our internationally renowned faculty address the importance of using field-directed therapy alone or combined with lesion-directed therapy to effectively treat both clinical and subclinical AK resulting in lower recurrence rates.

Click here for symposium details!

Unravelling the complexities of skin ageing: a multifaceted approach, sponsored by Walgreens Boots Alliance

Skin ageing is a complex phenomenon and only with a deep understanding of the biological processes involved can we develop the most efficacious solutions for consumers around the world. Walgreens Boots Alliance is on a quest to unravel this intricate mystery with a multifaceted research programme. The role of fibrillin-1 as an early marker of repair, sacrificial skin proteins as UV protectors and the role of mitochondria, the power stations of the cell, are some of the topics that will be discussed, together with the latest thinking on how epigenetics influences the ageing process.

Click here for symposium details!

Skin health in elderly – dermatological challenges, sponsored by Galderma

As we age, our skin becomes dryer, thinner and less elastic, making it more susceptible to complications. Besides having a negative impact on quality of life, aging skin problems place a substantial financial burden on healthcare systems. Xerosis is one of the most common skin problems, often causing pruritus, eczema, infection, and wounds. Pathophysiology, as well as recent epidemiologic data on dermatologic issues in the elderly, will be discussed. Results of a recent clinical study conducted in elderly patients to assess the performance and tolerability of a body wash and moisturizer formulated with filaggrin and ceramide technology will be presented.

Click here for your invitation to this satellite symposium!

How to influence skin microbiota in patients with chronic cutaneous diseases?, sponsored by La Roche-Posay Laboratoire Dermatologique

Skin, like other tissues such as the gut, is colonized by a dense community of commensal microorganisms. Changes in the composition of cutaneous microbial communities (a state of dysbiosis) have been linked to several chronic inflammatory skin diseases such as atopic dermatitis or psoriasis. Recent research about the composition of skin microbiota in these pathological conditions and healthy skin has substantially improved our understanding of their pathophysiology and the mutualistic interactions between human skin and its microbiota. This knowledge has opened a wide range of new therapeutic strategies to manage these two chronic inflammatory skin diseases more effectively.

Click here for symposium details!

New Frontiers in Antioxidant Research, sponsored by SkinCeuticals

1. Methods to differentiate environmental protection of topical antioxidants compositions (Dr. Zoe Draelos)
   1. Formulation parameters required for percutaneous absorption
   2. Analytical results of worldwide competitors
   3. Clinical results of worldwide competitors
2. Beyond UV spectrum: Cutaneous damage from infrared radiation and pollution (Dr. Jean Krutmann)
   1. Brief overview on photoaging
   2. IRA-induced damage and strategies of protection
   3. Pollution-induced damage and potential for protection
3. Cutaneous benefits of Resveratrol and the Nrf2 pathway as a novel mechanism in antioxidant research (Dr. Patricia Farris)
   1. History of Resveratrol
   2. Nrf2 pathway and endogenous antioxidant production
   3. Clinical results from Resveratrol BE
4. In the practice: Combined modalities of topical antioxidants and rejuvenating lasers (Dr. Jill Waibel)
   1. Clinical considerations of laser resurfacing
   2. Clinical benefits offered by antioxidants
   3. Clinical results combining C E Ferulic and rejuvenating lasers
   4. New frontiers in home treatment: Antioxidants and at-home laser therapy

A Match Made in Medicine: Identifying the right fit for your plaque psoriasis patients, sponsored by Celgene

This symposium will use a case-based approach to identify PsO patients who are in need of an innovative treatment solution that fits their everyday needs and lifestyle. The limitations of current treatment options for PsO will be reviewed and the clinical profile of a novel, oral therapy with the potential to meet the needs of various PsO patient types will be presented. Attendees will gain knowledge of the applicability of this new therapy in clinical practice.

Welcome to the urticaria clinic: A worldwide view, sponsored by Novartis Pharma AG

This symposium brings together a team of experts to raise chronic urticaria awareness in an educational and collaborative setting. The faculty will discuss patient cases in an informal ‘talk show’ style, highlighting their own particular learnings and experience. Audience interactivity will be utilised throughout each presentation, to allow attendees to collaborate as an additional member of the faculty. The ambitious overall goal of the symposium is to give physicians the confidence to treat patients with chronic urticaria in their own clinical practice and to raise expectations of treatment outcomes.

Click here for your invitation to this satellite symposium!

New Insights into Skin Ageing and Skin Health Using Systems Biology, sponsored by Procter and Gamble – Olay & SK-II

Systems Biology is a dynamic area of research that originated in the biomedical field but also offers great potential for unprecedented insights into skin function. This symposium will provide an overview of latest Systems Biology advances and share new fundamental research – including comparative analysis of molecular pathways across ages and ethnicities – that deepen our understanding of skin health and ageing. We will discuss how P&G is applying Systems Biology tools to create new models that help predict skin’s behaviour and identify new bioactives that can be used to create proven and effective technologies beneficial to both Dermatologists and patients.

Click here for symposium details!

How to manage infantile hemangiomas in 2015?, sponsored by Pierre Fabre Dermo-Cosmétique

Within the last years, classification of vascular anomalies has been revised and propranolol has opened a new era in the treatment of infantile hemangiomas. Based on cases, the experts will give a clear vision on diagnosis of infantile hemangiomas and the treatment options.

Why should I recommend advanced sunscreen? – a case based approach, sponsored by Johnson & Johnson

The primary environmental cause of aging of the skin and most skin cancers is ultraviolet light from the sun.

Its damaging effects are cumulative, so daily protection throughout life is important. SPF values of different sunscreens are linear and directly proportional to their respective sunburn protection levels and should be the primary consideration when choosing a sunscreen. Individual patient conditions are to be addressed in a case based approach using broad spectrum photo stable sunscreens. They can provide effective protection, as shown in studies improving bio-markers, if they contain effective UV filter systems and are used properly.

Isotretinoin in acne – An update on developments relevant to clinicians, sponsored by Cipher Pharma

Isotretinoin has been available for more than 3 decades and is the standard of treatment for severe and otherwise unresponsive acne. Over the past decade, there has been significant progress in understanding the mechanism of effect of this agent, optimizing bioavailability, clarifying the evidence regarding cumulative dose thresholds, use of alternative dosing including low dose regimens, the effectiveness of pregnancy prevention programs and research regarding potential adverse associations. These issues will be presented in a manner that will be of practical value to practicing dermatologists.

Using daylight to treat actinic keratosis: an innovative approach, sponsored by Galderma

Among other therapeutic choices in actinic keratosis (AK) treatment, conventional photodynamic therapy (c-PDT) using methyl-aminolevulinate and LED lamps is an effective treatment with cosmetic benefits, but requiring specific equipment. Using daylight PDT to activate methyl-aminolevulinate is a new option particularly suited to patients with AK on large areas on the face or scalp. It is simple, almost painless in most patients and shows similar efficacy to c-PDT, regardless of sunny or cloudy weather conditions. The speakers will review the shortcomings of current treatments, present the mode of action, clinical studies and treatment outcomes with this new therapeutic option.

Click here for your invitation to this satellite symposium!

FACIAL AESTHETICS: Advanced Techniques for Full Face Rejuvenation, sponsored by Merz

After a review of facial anatomy pertinent to rejuvenation, faculty will discuss the science of soft tissue fillers and neuromodulators and provide practical information on optimal selection and techniques for these agents based on their characteristics, indications, and efficacy, as well as patient assessment, gender, and goals. Potential adverse events and how to prevent them is also addressed. Following the didactic portion of the program, live demonstrations by the faculty will furnish attendees with valuable guidance on how to individualize treatment, including injection strategies, product selection and dosing, and aftercare.

Optimizing Outcomes in Advanced Basal Cell Carcinoma: A Multidisciplinary Approach to Patient Care, sponsored by Novartis Pharma AG

Advanced basal cell carcinoma (aBCC) can result in significant morbidity and disfigurement, dramatically impacting quality of life. This engaging program will provide attendees with an overview of multidisciplinary approaches to managing aBCC. Two opening presentations will review challenges associated with categorizing these rare tumors, current treatment options, and recent clinical data on hedgehog pathway inhibitor (HPI) therapy in aBCC. A panel of experts in dermatology, dermato-oncology, oncology, and surgery will then evaluate a series of cases, considering key decision points in the treatment course for each patient, and also discuss the role of HPI therapy in treating aBCC.

Click here for your invitation to this satellite symposium!

Male Hair Removal and Its Impact on the Skin, sponsored by Procter and Gamble – Gillette & Braun

Men typically remove their facial hair by electric shaving and/or blade shaving. The process of shaving represents a complex compromise in balancing robust removal of hair against minimizing impact to facial skin. Skin issues associated with poor hair removal practices are common but their aetiology often misunderstood by patients and physicians. This symposium describes how fundamental understanding of facial hair and skin leads to superior shaving solutions. By incorporating advanced scientific measurement and imaging technologies into clinical testing, we have gained better insights into how shaving technologies interact with skin and hair and how superior skin comfort can be achieved.

Click here for symposium details!

From Thermal Water to biotechnology: a journey into scientific thermalism, sponsored by Pierre Fabre Dermo-Cosmétique

Atopic dermatitis has a complex physiopathology that has yet to be understood. Acquiring knowledge about the intimate mechanisms of the condition will bring new therapeutic options and also different ways to look at “classic” methods. The accumulating data about the microbiome on one hand, and the study of the microflora in thermal waters on the other hand, has brought the Laboratoires Avène to the development of a biotechnological ingredient. I-modulia, an extract of Aquaphilus dolomiae bacterium discovered in the thermal spring, has shown interesting properties for pruritic and xerotic skin.

Adjunctive Therapies in the Treatment of Atopic Dermatisis, sponsored by Johnson & Johnson

The cause of atopic dermatitis involves both genetic and environmental factors.

In atopic dermatitis affected skin, the barrier dysfunction may lead to dry skin, skin irritation, micro-fissures and cracks, affecting patients’ quality of life.

Moisturizers/emollients are the cornerstone of atopic dermatitis treatment, alone or complementary to other treatment. They restore and preserve skin barrier integrity combat xerosis and transepidermal water loss of the skin.

They may enhance treatment efficacy, prevent disease exacerbation and reduce the need for steroids.

Colloidal oat based moisturizers are well-known for their repairing and soothing properties to help control flares and to reduce itching.

Current challenges and new horizons for hidradenitis suppurativa, sponsored by AbbVie

Hidradenitis suppurativa (HS) is a chronic, debilitating disease that is associated with significant physical and psychological impact on patients and their families. Although our awareness, knowledge and understanding have expanded over the past decade, gaps remain in clinical research and the understanding of the disease etiology and pathogenesis.

Dermatologists have a key role in improving outcomes for HS patients. Please join us for the HS symposium. Attendees will gain new insights into the clinical and patient-support decisions needed for optimal management of HS patients.

Real-World pSolutions for Psoriasis Patients, sponsored by Janssen

This symposium, entitled Real-World pSolutions for Psoriasis Patients, will employ a MEDTalk approach to present well-formulated, medically relevant ideas about “real-world” solutions to improve patient outcomes for psoriasis and psoriatic arthritis patients. Based on a concept originally developed by TED – a non-profit foundation aimed at sharing ideas and sparking conversation – our topics will be innovative, challenging to the status quo, and bring the latest evidence forward in an interesting and engaging format. Attendees will be inspired to take new knowledge back to their clinical practice and apply it through a personalized patient care approach.

Chenopodium Quinoa Co-Product Extract: A New, Naturally Derived Extract for Gentle Desquamation – An innovation from Kiehl’s, sponsored by Kiehl’s

Presentation of Chenopodium Quinoa Co-Product Extract, a new desquamation ingredient derived from plant by-products: its composition that led to interest as an exfoliating agent and research studies demonstrating its efficacy. The Kiehl’s technology incorporating Chenopodium Quinoa Co-Product Extract will be presented along with cosmeto-clinical and consumer perception testing results. Finally, insights from both dermatological peel procedures and the Kiehl’s technology will be shared.

Navigating the Psoriasis Storm, sponsored by Amgen

This symposium will investigate emerging therapies that target the inflammatory nature of psoriasis. Three engaging speakers will help navigate the psoriasis storm detailing inflammatory signaling and targeted therapeutic approaches. Dr. Griffiths reveals the hard-wired impact psoriasis has on peoples’ lives. Dr. Krueger ventures into the eye of the storm by reviewing the biological basis of inflammation in psoriasis pathogenesis. Dr. Papp weathers the storm by reviewing the latest on targeted therapeutic approaches and providing clinical perspectives on recent developments.

Click here for symposium details!

Hair Dye Allergies – Reducing the Risk Through Innovation, sponsored by Procter and Gamble – Wella

p-Phenylenediame (PPD) and p-toluylenediamine (PTD) are the most common ingredients in oxidative hair colorant products and guarantee outstanding colour results. However, they are known to be drivers of hair dye allergies making it important to identify new technologies which may help reduce the risk of allergy induction. Wella has identified a new gredient 2-methoxymethyl-p-phenylenediamine (ME-PPD or ME+), which combines reduced propensity to allergy induction with excellent colour results. This symposium will introduce this new innovation ME-PPD, share latest research data and will offer dermatologists a new perspective on the management of patients concerned regarding contact allergies or who have a proven hair dye allergy.

Click here for symposium details!

Improve total patient outcome and optimize your practice with advanced cleansing technology, sponsored by Clarisonic

Clarisonic is the worldwide leader in skin cleansing devices. Join us for a discussion on how dermatologists and plastic surgeons build their practices by recommending our sonic skin cleansing device to their patients with acne and other skin conditions, as well as using our device as a pre-treatment for glycolic peels, IPL and other procedures. We will also discuss the use of cosmeceuticals in the dermatology practice as well as the effects of air pollution on the skin and the importance of gentle, thorough daily cleansing for healthy skin.

Click here for your invitation to this satellite symposium!

Sun and Environment: Get Connected, Get Protected, sponsored by L’Oréal Research and Innovation

An increasing tension concerning environmental ageing and life expectancy is mounting in the medical community; research has an important role to play in the debate and in finding technical solutions for one of modern society’s dilemmas. A better understanding and characterization of the amazing diversity in skin pigmentation worldwide could bring real added-value to consumers.

Better knowledge will most certainly be vital, if product lines are accompanied by stretchable bioelectronics devices and applications that allow a consumer to choose a skin product adapted to his or her condition. For instance: a sunscreen that takes into account local sunlight and pollution as well as the individual’s pigmentation.

Beyond wrinkles, volume: a universal expectation, when aesthetic procedures inspire new cosmetic technologies, sponsored by L’Oréal Paris

This symposium will show the importance of understanding the skin biological response to aesthetic procedures, to develop new anti-aging cosmetic solutions.

Click here for symposium details!

Challenging cases in the management of psoriatic disease: from childhood to adulthood, sponsored by AbbVie

This AbbVie-sponsored case-based symposium will provide a practical approach to managing patients with psoriatic disease, from childhood, through adolescence, to adulthood in everyday clinical practice. Our eminent faculty will share with you their experiences in treating challenging cases in psoriatic disease.

Bring your own challenging cases for discussion! You will have opportunities to discuss your own challenging cases with the experts and colleagues during a panel discussion and open-floor Q&A session.

Practical Approaches for Enhancing Patient Care and Satisfaction in Psoriasis, sponsored by Pfizer

The lifelong burden of psoriasis encompasses not just physical, but also psychological, social, and economic factors that may significantly impact your patients’ lives. In order to enhance outcomes and satisfaction for patients with psoriasis, it is important to establish and address individualized patient treatment goals. Some symptoms and presentations of psoriasis, such as itch and nail or scalp manifestations, can have a greater negative impact on patient quality of life than those included in measures of skin disease alone. In addition, significant comorbidities may exist, some of which may be readily apparent, while others are silent and not obvious to the patient. By following a practical framework that includes collaborative goal setting, takes into account the patient’s most bothersome symptoms, and considers the overall health of the patient, dermatologists may improve patient care and satisfaction.

Advances in Atopic Dermatitis: Expert Insights Into New and Emerging Therapies, sponsored by Anacor Pharmaceuticals, Inc.

Atopic dermatitis (AD) is an inflammatory, relapsing disorder that is chronic in nature. It can result from a number of different factors including genetics, immune system dysfunction, and possibly environmental exposures. Because there is no known cure, treating patients with AD can be challenging and often frustrating for both the clinician and the patient. This continuing medical education program provides information on the role of immune abnormalities and skin-barrier dysfunction in the development of AD and how this understanding informs and can help guide treatment selection. Expert faculty will discuss the 2014 AAD guidelines and other recent guidelines for diagnosis and management of AD, and summarize data on current and emerging topical and systemic therapies to help providers optimize treatment outcomes.

Exploring the Challenges in Identifying and Managing Patients with Advanced Basal Cell Carcinoma, sponsored by Hoffman-La Roche Limited

This symposium will provide an overview of the multiple facets and clinical features that patients with Advanced Basal Cell Carcinoma (aBCC) may present with and the challenges Dermatologists may face in identifying these patients. For such patients, the faculty will discuss the role of and need for the multidisciplinary team in treating and optimizing patient outcomes as well as share tips on the practical management of those patients treated with a hedgehog pathway inhibitor.

Women at menopause: Cutting edge science for skin health and beauty, sponsored by Vichy Laboratoires

With the increase of life expectancy, menopause represents a third of a woman’s life. Dermatologists are increasingly confronted with consultations for alterations of skin quality and function parameters such as dryness, loss of firmness and elasticity. The aim of the symposium is to share cutting edge science for skin health and beauty of menopausal women.

Click here for symposium details!

Revealing the invisible impact of dermatological conditions: integrated approaches to chronic hand eczema and facial acne management, sponsored by Stiefel

Successful treatment of patients with dermatological conditions can be clinically challenging. In this symposium, we will uncover the invisible impact of skin conditions such as chronic hand eczema and facial acne on patients’ lives ^{1 2}. We will review evidence-based treatment options and use case studies to discuss practical approaches to optimise outcomes. We will reveal how an integrated approach to patient care can optimise your patients’ skin health. There will be plenty of opportunity for interaction in what promises to be a highly stimulating symposium. The symposium will include clinical data on Stiefel products.

1. Boehm T. et al. Anxiety, depression and impaired health-related quality of life in patients with occupational hand eczema. Contact Dermatitis 2012;67:184-92.
2. Ahmed A. et al. Quality-of-life effects of common dermatological diseases. Semin Cutan Med Surg 2013;32:101-9.

Click here for symposium details!

BIOPHOTONICS – TRANSFORMATIONAL INNOVATION FOR THE SKIN, sponsored by LEO Pharma

Inflammation and impaired healing are features of a wide range of dermatological conditions. The innovative BioPhotonic system provides unique light delivery designed to stimulate the skin’s own repair systems and normalise cellular activity. This promises to improve treatment choice and outcomes for many patients with dermatological conditions, including millions of acne sufferers worldwide, who may currently be offered treatments with poor efficacy or severe side effects. Our internationally renowned faculty will present pivotal efficacy and safety data for BioPhotonics in moderate to severe acne, including long-term outcomes. We will explore the principles and potential of this truly unique, game-changing treatment.